Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
FEASIBILITY AND LATE OUTCOMES OF TAVR IN HIGH-RISK PATIENTS WITH PURE AORTIC REGURGITATION
Anno:
2026
Background and Aim: Transfemoral aortic valve replacement (TAVR) for pure aortic regurgitation (AR) remains under-investigated, with limited data available regarding long-term outcomes. Methods: From January 2019 to June 2025, 15 patients (median age 71 years; range 47–86; 50% female) undergoing TAVR for pure AR were included in this retrospective…
IATROGENIC VENTRICULAR SEPTAL DEFECT FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION: A SINGLE-CENTER EXPERIENCE OF A RARE COMPLICATION.
Anno:
2026
Introduction. Gerbode’s defect dates back to 1857. It generally has a congenital etiology, however very rare acquired forms have been described as complications of cardiac surgery, bacterial endocarditis, thoracic trauma, myocardial infarction or Transcatheter Aortic Valve Implant (TAVI). Diagnosing the communication between the left ventricle and the right atrium…
VALVE-IN-VALVE TAVI FOR DEGENERATED AORTIC BIOPROSTHESIS IN AN ELDERLY MULTIMORBID PATIENT: A HEART TEAM–DRIVEN APPROACH
Anno:
2026
Population ageing and improved survival after cardiovascular interventions have led to a growing number of elderly, multimorbid patients with complex valvular heart disease (VHD). In particular, structural degeneration of aortic bioprostheses has become an increasingly frequent cause of severe valvular dysfunction and heart failure (HF) in patients with a…
EARLY SIGNIFICANT THROMBOCYTOPENIA AFTER TAVI IN A PATIENT WITH A MECHANICAL MITRAL VALVE: WHEN A PROCEDURAL PATTERN MIMICS HIT
Anno:
2026
BACKGROUND: Thrombocytopenia is common after transcatheter aortic valve implantation (TAVI) and is often a self-limited procedural phenomenon. In patients requiring peri-procedural heparin bridging, the early platelet drop may raise concern for heparin-induced thrombocytopenia (HIT) and prompt potentially hazardous changes in anticoagulation. CASE PRESENTATION: A 73-year-old man with permanent atrial…
OPTIMIZING TAVR WITH FIFTH-GENERATION SELF-EXPANDING VALVES: A SINGLE-CENTER COMPARATIVE ANALYSIS
Anno:
2026
INTRODUCTION Transcatheter Aortic Valve Replacement (TAVR) is becoming the standard of care in the modern era of cardiac surgery to treat patients with aortic valve disease. Continuous technological improvement has recently introduced the fifth-generation of the self-expanding Medtronic platform. The aim of the study was to compare the early…
AN UNUSUAL SIMULTANEOUS KISSING BALLOON INFLATION
Anno:
2026
BACKGROUND Transcatheter mitral valve-in-valve implantation (TMVIV) into failing surgical bioprosthetic valves has evolved in recent years as a promising therapy to avoid redo cardiac surgery in patients at high surgical risk. METHODS An 80-year-old female patient with CKD stage 3, hypertension, a permanent PMK and atrial fibrillation was referred…